Home / Diabetes – Clinical Trials and Research

Diabetes – Clinical Trials and Research


Add to existing insulin therapy. Effectiveness and safety of oral semaglutide versus placebo in people with type 2 diabetes who are receiving insulin therapy.

Randomized, Douple-blind, Placebo-controlled, Parallel group study to Assess Cardiovascular Outcomes Following Treatment with Ertugliflozin (MK-8835/PF-04971729) in Subjects with Type 2 Diabetes Mellitus and Established Vascular Disease.

Non-Interventional multicentre study evaluating the quality of life and clinical characteristics of patients with peripheral arterial disease (PAD) treated with cilostazol.

Randomized, double-blind, placebo-controlled, parallel-group, multicenter study to demonstrate the effects of sotagliflozin on cardiovascular and renal events in type 2 diabetic patients, cardiovascular risk factors and moderate renal impairment.

Study of the rib changes in corneal in Vivo Corneal Confocal Microscopy (CCM) as compared to the skin biopsy results in diabetic patients for the early diagnosis, evaluation of severity and monitoring of chronic diabetic neuropathy.

Study on the relationship between diabetic neuropathy with circulating biomarkers.

Study of repeatability of a standardized test meal on postprandial lipaemia.

Diabetes Type 2 diabetes, retinopathy and psychological parameters.

Diabetes Type 2 diabetes, fatty liver disease and diabetes complications.

The importance of postprandial lipaemia on cardiac morbidity and mortality in individuals increased cardiovascular risk: Study HPLS.